NewsMarkets

Health

US Government Funds $41 Million to Test Alzheimer's Prevention Drugs

The Advanced Research Projects Agency for Health is expanding clinical trials of supplements and approved drugs to prevent dementia in at-risk individuals.

1 publisher · 1 article · first seen 21 Oct 2026 · updated 17d ago

Headline and summary written by an AI model from the linked article; not reviewed by a person. How this was made

This story has stopped developing; this page is its permanent record. More from that day

The story so far

1 publisher has covered this in 1 article since 21 Oct 2026. Latest News from Science Magazine published first, on 21 October at 04:05 UTC.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. With blood test looming, government puts $41 million into clinical trials to ward off Alzheimer’s disease Latest News from Science Magazine ·

In this story

  • Advanced Research Projects Agency for Health
  • Science Magazine
Embed this story

Paste this into any web page to show the live odds, with a link back here.